Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spontaneous bacterial peritonitis.

J C Hoefs, B A Runyon

    Disease-A-Month : DM
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Spontaneous bacterial peritonitis (SBP) is a serious infection in patients with chronic liver disease. Early diagnosis via paracentesis and prompt antibiotic treatment are crucial for reducing SBP mortality.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.

    Alimentary pharmacology & therapeutics·2008
    Same author

    The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.

    Alimentary pharmacology & therapeutics·2008
    Same author

    Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt.

    Alimentary pharmacology & therapeutics·2007
    Same author

    TIPS versus paracentesis for cirrhotic patients with refractory ascites.

    The Cochrane database of systematic reviews·2006
    Same author

    TIPS versus paracentesis for cirrhotic patients with refractory ascites.

    The Cochrane database of systematic reviews·2004
    Same author

    Early events in spontaneous bacterial peritonitis.

    Gut·2004
    Same journal

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    Periodontal disease and diabetic kidney disease: A comprehensive analysis.

    Disease-a-month : DM·2026
    Same journal

    Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

    Disease-a-month : DM·2026
    Same journal

    Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

    Disease-a-month : DM·2026
    Same journal

    Foreword for periodontal disease and diabetic kidney disease: A comprehensive analysis.

    Disease-a-month : DM·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Spontaneous bacterial peritonitis (SBP) is a severe infection of ascitic fluid, predominantly affecting patients with advanced chronic liver disease.
    • SBP can present with subtle or absent clinical signs, necessitating a high index of suspicion for early diagnosis.
    • Patients with severe intrahepatic shunting or low ascitic fluid protein (<1 g/dl) are at increased risk.

    Observation:

    • Diagnosis requires abdominal paracentesis, recommended for all hospitalized patients with ascites and repeated if infection is suspected.
    • Optimizing ascitic fluid culture yield involves immediate bedside inoculation of blood culture bottles.
    • High mortality rates associated with SBP underscore the need for timely intervention.

    Findings:

    Related Experiment Videos

    • Routine admission paracentesis and empiric third-generation cephalosporin therapy may decrease SBP mortality, especially if Gram stain is positive or neutrophil count >250 cells/cu mm.
    • Repeating paracentesis after 48 hours to reassess neutrophil count is key to evaluating treatment efficacy.
    • Appropriate antimicrobial therapy should result in a >50% decrease in ascitic fluid neutrophils within 48 hours.

    Implications:

    • Prompt diagnosis and treatment of SBP are critical for improving patient outcomes.
    • Further research is needed to establish optimal antibiotic duration and preventative strategies for SBP.
    • Parenteral antibiotic treatment for 10–14 days is currently recommended in the absence of definitive trial data.